Literature DB >> 34106763

Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than BRCA1 or BRCA2.

Mark Robson1.   

Abstract

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in the Journal of Clinical Oncology, to patients seen in their own clinical practice.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34106763      PMCID： PMC8330962          DOI： 10.1200/JCO.21.00999

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


  45 in total

1.  Pathogenic Germline Variants in 10,389 Adult Cancers.

Authors:  Kuan-Lin Huang; R Jay Mashl; Yige Wu; Deborah I Ritter; Jiayin Wang; Clara Oh; Marta Paczkowska; Sheila Reynolds; Matthew A Wyczalkowski; Ninad Oak; Adam D Scott; Michal Krassowski; Andrew D Cherniack; Kathleen E Houlahan; Reyka Jayasinghe; Liang-Bo Wang; Daniel Cui Zhou; Di Liu; Song Cao; Young Won Kim; Amanda Koire; Joshua F McMichael; Vishwanathan Hucthagowder; Tae-Beom Kim; Abigail Hahn; Chen Wang; Michael D McLellan; Fahd Al-Mulla; Kimberly J Johnson; Olivier Lichtarge; Paul C Boutros; Benjamin Raphael; Alexander J Lazar; Wei Zhang; Michael C Wendl; Ramaswamy Govindan; Sanjay Jain; David Wheeler; Shashikant Kulkarni; John F Dipersio; Jüri Reimand; Funda Meric-Bernstam; Ken Chen; Ilya Shmulevich; Sharon E Plon; Feng Chen; Li Ding
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

2.  Family history and the risk of breast cancer: a systematic review and meta-analysis.

Authors:  P D Pharoah; N E Day; S Duffy; D F Easton; B A Ponder
Journal:  Int J Cancer       Date:  1997-05-29       Impact factor: 7.396

3.  Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.

Authors:  Allison W Kurian; Kevin C Ward; Ann S Hamilton; Dennis M Deapen; Paul Abrahamse; Irina Bondarenko; Yun Li; Sarah T Hawley; Monica Morrow; Reshma Jagsi; Steven J Katz
Journal:  JAMA Oncol       Date:  2018-08-01       Impact factor: 31.777

4.  A map of human genome variation from population-scale sequencing.

Authors:  Gonçalo R Abecasis; David Altshuler; Adam Auton; Lisa D Brooks; Richard M Durbin; Richard A Gibbs; Matt E Hurles; Gil A McVean
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

5.  Pathogenic Variants in CHEK2 Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast Cancer.

Authors:  Stephanie L Greville-Heygate; Tom Maishman; William J Tapper; Ramsey I Cutress; Ellen Copson; Alison M Dunning; Linda Haywood; Louise J Jones; Diana M Eccles
Journal:  JCO Precis Oncol       Date:  2020-05-04

6.  Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.

Authors:  Jenna Lilyquist; Holly LaDuca; Eric Polley; Brigette Tippin Davis; Hermela Shimelis; Chunling Hu; Steven N Hart; Jill S Dolinsky; Fergus J Couch; David E Goldgar
Journal:  Gynecol Oncol       Date:  2017-09-07       Impact factor: 5.482

7.  Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.

Authors:  Anne S Reiner; Mark E Robson; Lene Mellemkjær; Marc Tischkowitz; Esther M John; Charles F Lynch; Jennifer D Brooks; John D Boice; Julia A Knight; Sharon N Teraoka; Xiaolin Liang; Meghan Woods; Ronglai Shen; Roy E Shore; Daniel O Stram; Duncan C Thomas; Kathleen E Malone; Leslie Bernstein; Nadeem Riaz; Wendy Woodward; Simon Powell; David Goldgar; Patrick Concannon; Jonine L Bernstein
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

8.  ATM mutations in patients with hereditary pancreatic cancer.

Authors:  Nicholas J Roberts; Yuchen Jiao; Jun Yu; Levy Kopelovich; Gloria M Petersen; Melissa L Bondy; Steven Gallinger; Ann G Schwartz; Sapna Syngal; Michele L Cote; Jennifer Axilbund; Richard Schulick; Syed Z Ali; James R Eshleman; Victor E Velculescu; Michael Goggins; Bert Vogelstein; Nickolas Papadopoulos; Ralph H Hruban; Kenneth W Kinzler; Alison P Klein
Journal:  Cancer Discov       Date:  2011-12-29       Impact factor: 39.397

9.  BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.

Authors:  Nana Weber-Lassalle; Jan Hauke; Juliane Ramser; Lisa Richters; Eva Groß; Britta Blümcke; Andrea Gehrig; Anne-Karin Kahlert; Clemens R Müller; Karl Hackmann; Ellen Honisch; Konstantin Weber-Lassalle; Dieter Niederacher; Julika Borde; Holger Thiele; Corinna Ernst; Janine Altmüller; Guido Neidhardt; Peter Nürnberg; Kristina Klaschik; Christopher Schroeder; Konrad Platzer; Alexander E Volk; Shan Wang-Gohrke; Walter Just; Bernd Auber; Christian Kubisch; Gunnar Schmidt; Judit Horvath; Barbara Wappenschmidt; Christoph Engel; Norbert Arnold; Bernd Dworniczak; Kerstin Rhiem; Alfons Meindl; Rita K Schmutzler; Eric Hahnen
Journal:  Breast Cancer Res       Date:  2018-01-24       Impact factor: 6.466

10.  Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

Authors:  Taru A Muranen; Dario Greco; Carl Blomqvist; Kristiina Aittomäki; Sofia Khan; Frans Hogervorst; Senno Verhoef; Paul D P Pharoah; Alison M Dunning; Mitul Shah; Robert Luben; Stig E Bojesen; Børge G Nordestgaard; Minouk Schoemaker; Anthony Swerdlow; Montserrat García-Closas; Jonine Figueroa; Thilo Dörk; Natalia V Bogdanova; Per Hall; Jingmei Li; Elza Khusnutdinova; Marina Bermisheva; Vessela Kristensen; Anne-Lise Borresen-Dale; Julian Peto; Isabel Dos Santos Silva; Fergus J Couch; Janet E Olson; Peter Hillemans; Tjoung-Won Park-Simon; Hiltrud Brauch; Ute Hamann; Barbara Burwinkel; Frederik Marme; Alfons Meindl; Rita K Schmutzler; Angela Cox; Simon S Cross; Elinor J Sawyer; Ian Tomlinson; Diether Lambrechts; Matthieu Moisse; Annika Lindblom; Sara Margolin; Antoinette Hollestelle; John W M Martens; Peter A Fasching; Matthias W Beckmann; Irene L Andrulis; Julia A Knight; Hoda Anton-Culver; Argyrios Ziogas; Graham G Giles; Roger L Milne; Hermann Brenner; Volker Arndt; Arto Mannermaa; Veli-Matti Kosma; Jenny Chang-Claude; Anja Rudolph; Peter Devilee; Caroline Seynaeve; John L Hopper; Melissa C Southey; Esther M John; Alice S Whittemore; Manjeet K Bolla; Qin Wang; Kyriaki Michailidou; Joe Dennis; Douglas F Easton; Marjanka K Schmidt; Heli Nevanlinna
Journal:  Genet Med       Date:  2016-10-06       Impact factor: 8.822
View more
  2 in total

1.  Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes.

Authors:  Allison W Kurian; Paul Abrahamse; Kevin C Ward; Ann S Hamilton; Dennis Deapen; Jonathan S Berek; Lily Hoang; Amal Yussuf; Jill Dolinsky; Krystal Brown; Thomas Slavin; Timothy P Hofer; Steven J Katz
Journal:  JCO Precis Oncol       Date:  2021-12-22

2.  Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants.

Authors:  Ana Carolina Leite Vieira Costa Gifoni; Markus Andret Cavalcante Gifoni; Camila Martins Wotroba; Edenir Inez Palmero; Eduardo Leite Vieira Costa; Wellington Dos Santos; Maria Isabel Achatz
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.